AtomX
Enterprise number 0789299094 · Active (000 Normale toestand)
AtomX is a besloten vennootschap registered in Chastre, Belgium, incorporated on 2 Aug 2022. Its registered activity is overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied.
Company details
- Enterprise number
- 0789299094 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 2 Aug 2022 (4 years)
- Registered address
- 1450 Chastre
- Province
- Walloon Brabant
- Activity
- 72190 Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
- Industry
- Scientific research and development
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Walloon Brabant
- "CLINICAL & QUALITY SUPPORT" Villers-la-Ville
- ABAXYS THERAPEUTICS Villers-la-Ville
- ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION Lasne
- ADBDL Médecine et Sciences médicales Wavre
- ALANINE Lasne
- ALLSIGHTSAFRICA Orp-Jauche
- ANSERS Perwez
- AQYLA BioVenture Builder Wavre
- ARSALIS Genappe
- ART - OS Waterloo
- ARTLINOW Lasne
- ARXIOS Genappe
Questions about AtomX
What is the enterprise number of AtomX?
AtomX is registered under enterprise number 0789299094 in the official register of Belgium. View it at the official register.
Is AtomX still active?
Yes. AtomX is registered as active (status: 000 Normale toestand).
Has AtomX gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for AtomX in the official data.
When was AtomX founded?
AtomX was incorporated on 2 Aug 2022.
Where is AtomX registered?
AtomX's registered address is in 1450 Chastre (Walloon Brabant), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.